Lang E, Bissinger R, Gulbins E, Lang F
Moreover, Novo states that no head-to-head trial has compared the highest approved doses of Zepbound and Wegovy
The entire premise rested on pharmacological theory, not evidence
A few years later, I was diagnosed with binge eating disorder a diagnosis I now expect to be inaccurate based on how much this medication has helped me
Most GLP-1 medications target one receptor
This makes the combination logical, but it is important to emphasize that there is not yet a large human trial in which exactly this full stack NMN + TMG + GlyNAC has been tested long-term on hard endpoints such as biological age, disease prevention, or lifespan